These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9830748)
1. [Analgesic response and secondary effects in patients with osteoblastic metastasis, treated with Samarium 153 ethylenediaminotetramethylenephosphate]. Lovera C; Massardo T; Galleguillos MC; González P; Comparini B; Yáñez M; Fodor M; Gil MC; Araya G; Tomicic M Rev Med Chil; 1998 Aug; 126(8):963-71. PubMed ID: 9830748 [TBL] [Abstract][Full Text] [Related]
2. A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Resche I; Chatal JF; Pecking A; Ell P; Duchesne G; Rubens R; Fogelman I; Houston S; Fauser A; Fischer M; Wilkins D Eur J Cancer; 1997 Sep; 33(10):1583-91. PubMed ID: 9389919 [TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer. Dolezal J; Vizda J; Odrazka K Urol Int; 2007; 78(1):50-7. PubMed ID: 17192733 [TBL] [Abstract][Full Text] [Related]
4. (153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies. Correa-González L; Arteaga de Murphy C; Pichardo-Romero P; Pedraza-López M; Moreno-García C; Correa-Hernández L Arch Med Res; 2014 May; 45(4):301-8. PubMed ID: 24681187 [TBL] [Abstract][Full Text] [Related]
5. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain. Liepe K; Runge R; Kotzerke J J Cancer Res Clin Oncol; 2005 Jan; 131(1):60-6. PubMed ID: 15449184 [TBL] [Abstract][Full Text] [Related]
6. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. Serafini AN; Houston SJ; Resche I; Quick DP; Grund FM; Ell PJ; Bertrand A; Ahmann FR; Orihuela E; Reid RH; Lerski RA; Collier BD; McKillop JH; Purnell GL; Pecking AP; Thomas FD; Harrison KA J Clin Oncol; 1998 Apr; 16(4):1574-81. PubMed ID: 9552068 [TBL] [Abstract][Full Text] [Related]
7. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma. Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585 [TBL] [Abstract][Full Text] [Related]
8. Samarium-153 lexidronam for painful bone metastases. Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284 [No Abstract] [Full Text] [Related]
9. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study. Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study. Yuan J; Liu C; Liu X; Wang Y; Kuai D; Zhang G; Zaknun JJ Clin Nucl Med; 2013 Feb; 38(2):88-92. PubMed ID: 23334120 [TBL] [Abstract][Full Text] [Related]
11. Treatment of bone pain secondary to metastases using samarium-153-EDTMP. Etchebehere EC; Pereira Neto CA; Lima MC; Santos Ade O; Ramos CD; Silva CM; Camargo EE Sao Paulo Med J; 2004 Sep; 122(5):208-12. PubMed ID: 15558143 [TBL] [Abstract][Full Text] [Related]
12. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases. Bayouth JE; Macey DJ; Kasi LP; Fossella FV J Nucl Med; 1994 Jan; 35(1):63-9. PubMed ID: 7505819 [TBL] [Abstract][Full Text] [Related]
13. [153Sm-EDTMP for moderate and severe bone cancer pain]. Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058 [TBL] [Abstract][Full Text] [Related]
14. [Primary investigation of dose-effect relationship of 153Sm-EDTMP in treating multiple bone metastases]. Fan W; Chen LX; Liu XW; Tang Q; Wang GH; Zhi SF; Zeng ZY Ai Zheng; 2006 Nov; 25(11):1395-8. PubMed ID: 17094908 [TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of bone pain palliation after samarium-153-EDTMP therapy. Sapienza MT; Ono CR; Guimarães MI; Watanabe T; Costa PA; Buchpiguel CA Rev Hosp Clin Fac Med Sao Paulo; 2004 Dec; 59(6):321-8. PubMed ID: 15654484 [TBL] [Abstract][Full Text] [Related]
16. Samarium-153 ethylenediamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases. Tripathi M; Singhal T; Chandrasekhar N; Kumar P; Bal C; Jhulka PK; Bandopadhyaya G; Malhotra A Indian J Cancer; 2006; 43(2):86-92. PubMed ID: 16790946 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases. Liepe K; Kotzerke J Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384 [TBL] [Abstract][Full Text] [Related]